Fentanyl Nasal Spray

DRUG3 trials

Sponsors

CCDRD Cooperative Clinical Drug Research and Development AG, 5med GmbH, M.D. Anderson Cancer Center

Conditions

Advanced CancersPainPostoperative pain relief

Phase 3

A randomized, parallel group, multi-center study of a fentanyl nasal spray compared with placebo nasal spray for postoperative pain management and prolonged open treatment over up to 120 hours postoperatively compared with intravenous patient-controlled analgesia using morphine

RecruitingCTIS2024-519625-38-00

CCDRD Cooperative Clinical Drug Research and Development AG, 5med GmbHPostoperative pain relief

Start: 2024-04-14Target: 160Updated: 2026-01-27

Phase 4

Fentanyl for Breakthrough Pain in the Emergency Department

TerminatedNCT01812759

M.D. Anderson Cancer CenterPain

Start: 2014-01-10End: 2014-10-22Updated: 2021-06-29

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

CompletedNCT02459964

M.D. Anderson Cancer CenterAdvanced Cancers, Pain

Start: 2015-09-14End: 2020-06-21Updated: 2021-06-16

Related Papers

Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial

PLoS ONE2020-07-1026 citations